Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13462490 | 1.00 | THRB (0.41) | THRBMEN1KMT2ASHBG | |
| SCHEMBL13952341 | 1.00 | THRB (0.41) | THRBMEN1KMT2ASHBG | |
| SCHEMBL13952290 | 1.00 | THRB (0.41) | THRBMEN1KMT2ASHBG | |
| SCHEMBL13716849 | 0.84 | DPP4 (0.34) | THRBMEN1KMT2A | |
| SCHEMBL25972352 | 0.83 | — | — | |
| SCHEMBL24742714 | 0.79 | THRB (0.39) | THRBMEN1KMT2ASHBG | |
| SCHEMBL9439852 | 0.79 | THRB (0.39) | THRBMEN1KMT2ASHBG | |
| SCHEMBL9154707 | 0.79 | THRB (0.39) | THRBMEN1KMT2ASHBG | |
| SCHEMBL2451853 | 0.79 | THRB (0.39) | THRBMEN1KMT2ASHBG | |
| SCHEMBL9402900 | 0.79 | THRB (0.39) | THRBMEN1KMT2ASHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054472-A1 | Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof | TEIJIN PHARMA LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054472-A1 | Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof | MAPKAPK2, MAPKAPK5, MAPKAPK3 | THRB 3409/4885MEN1 1213/4885KMT2A 979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.